MarkAlexanderMatzaMDMBA

PubMed

• Musculoskeletal ultrasound characteristics of checkpoint inhibitor-associated inflammatory arthritis.
  Mazen Nasrallah, Greg Challener, Sara Schoenfeld, Mark Matza, Donald Lawrence
  Seminars in Arthritis and Rheumatism. 2024-12-01
• Imaging Challenges and Developments in Large-vessel Vasculitis.
  Mark A Matza, Ana B Arevalo, Sebastian Unizony
  Rheumatic Diseases Clinics of North America. 2024-11-01
• Current and Emerging Approaches to Imaging Large Vessel Vasculitis.
  Ahmed Tawakol, Brittany Nicole Weber, Michael T Osborne, Mark A Matza, Vinit Baliyan
  Circulation. Cardiovascular Imaging. 2024-11-01

Journal Articles

• Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheu...  
  Keller KK, Mukhtyar CB, Nielsen AW, Hemmig AK, Mackie SL, Sattui SE, Hauge EM, Dua A, Helliwell T, Neill L, Blockmans D, Devauchelle-Pensec V, Hayes E, Venneboer AJ, ..., Annals of the Rheumatic the Diseases, 12/1/2023
• Treatment for giant cell arteritis with 2 months of prednisone in combination with tocilizumab: A single-arm, open-label, proof-of-concept study  
  Sebastian Unizony, MD, Mark A. Matza, MD, Adam Jarvie, BA, David O’Dea, BSB, Ana D. Fernandes, MA and Prof. John H. Stone, MD, Lancet Rheumatology, 11/2/2023
• Case 12-2022: A 41-Year-Old Woman with Transient Ischemic Attack and Mitral Valve Masses  
  Matza MA, Rincon SP, Yucel E, Jorge AM, Singhal AB, Coleman CA, Uljon SN, New England Journal of Medicine, 4/21/2022
• Ustekinumab for the treatment of Giant Cell Arteritis  
  Matza MA, Fernandes AD, Stone JH, Unizony SH, Arthritis Care Research, 6/2021
• Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia  
  Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA, Ebert BL, Al- Shahrour F, Hasserjian RP, Scadden EO, Aung Z, Matza M, Merkenschlager M, Lin C..., Nature, 4/8/2010
• Join now to see all